substance p has been researched along with methylprednisolone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellote, JM; Kingery, WS; Maze, M | 1 |
| Agashe, GS; Clark, JD; Davies, MF; Kingery, WS; Maze, M; Sawamura, S | 1 |
| Hong, HS; Lee, ZH; Son, Y; Um, J | 1 |
3 other study(ies) available for substance p and methylprednisolone
| Article | Year |
|---|---|
Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds.
Topics: Animals; Anti-Inflammatory Agents; Axotomy; Dose-Response Relationship, Drug; Edema; Evans Blue; Glucocorticoids; Hindlimb; Hyperalgesia; Male; Methylprednisolone; Neurogenic Inflammation; Nociceptors; Pain Threshold; Rats; Rats, Sprague-Dawley; Reflex; Sciatic Nerve; Substance P | 1999 |
Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression.
Topics: Animals; Complex Regional Pain Syndromes; Hyperalgesia; Immunohistochemistry; Male; Methylprednisolone; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Spinal Cord; Substance P | 2001 |
Long-term comparative study of Substance-P with methylprednisolone on the development of osteoporosis.
Topics: Animals; Anti-Inflammatory Agents; Blood Glucose; Body Weight; Bone Density; Cell Movement; Collagen; Dexamethasone; Humans; Injections; Male; Methylprednisolone; Osteoporosis; Rats; Rats, Sprague-Dawley; Stem Cells; Substance P; Time Factors | 2014 |